The University of Greenwich have developed drug treatments targetting fatal cytokine storm symptom of Covid-19.

Dr Mike Leach has developed compounds, known as UoG-alpha and UoG-beta, that can inhibit the multiple cytokine proteins that can cause death by respiratory collapse, following Covid 19 infection. These compounds can be used within a drug therapy to prevent our immune system from disabling the body’s lung function during a cytokine storm; one of the contributing factors in Covid-19 deaths. This treatment could potentially also help protect cancer and organ transplant patients.

Further reading